Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 1 pseudogene 4 (PRELID1P4) is listed as a human pseudogene, meaning it is a **non-protein-coding genetic relic** derived from the parent gene PRELID1. Pseudogenes generally do not produce functional proteins and are not recognized as molecular drug targets. There are no studies implicating PRELID1P4 specifically in particular biological functions or diseases, nor are there known interacting drugs or therapeutic mechanisms. The parent gene PRELID1 encodes a mitochondrial protein involved in apoptotic pathways and phospholipid transfer, but PRELID1P4 does not share these functions[3][4][6]. Searches for PRELID1P4 yield no evidence for functional protein-coding capacity or direct disease involvement.\n\nAdditional clarification:\n- PRELID1P4 is a *pseudogene*, not a bona fide gene or receptor, and there is no evidence suggesting it's a therapeutic target in the current biomedical literature[7].\n- PRELID1 (not PRELID1P4) is a mitochondrial protein involved in phospholipid transfer and apoptosis regulation, and variations in PRELID1 are discussed in disease contexts like cancer, but these facts are *not* directly transferable to the pseudogene PRELID1P4[3][4][5][6].\n\nIf you are seeking information on the functional and druggable target, you may want to query **PRELID1** (PRELI domain-containing 1), rather than the pseudogene PRELID1P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 1 pseudogene 4 (PRELID1P4).